Graney & King’s Amgen AMGN Stock Holding History

Graney & King’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.8K	Hold	150	–	–	0.03%	139
2025 Q4	$49.1K	Hold	150	–	–	0.03%	140
2025 Q3	$42.3K	Hold	150	–	–	0.03%	145
2025 Q2	$41.9K	Hold	150	–	–	0.03%	141
2025 Q1	$46.7K	Hold	150	–	–	0.03%	126
2024 Q4	$39.1K	Buy	+150	New	+$44.5K	0.03%	138

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Graney & King's AMGN Position: Q1 2026 in Review

Graney & King held its Amgen (AMGN) position steady in Q1 2026 at 150 shares worth $52.8K. The position accounts for 0.03% of the portfolio, ranked #139.

Graney & King first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Graney & King held 150 shares of Amgen worth $52.8K as of Q1 2026.
Graney & King left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.03% of Graney & King's portfolio in Q1 2026, its #139 holding.
Graney & King first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.